Maxim Group Downgrades Sucampo Pharmaceuticals (SCMP) to Hold Following Acquisition; Sees Low Probability of Another Bidder Dec 26, 2017 10:46AM
Sucampo Pharmaceuticals (SCMP) PT Raised to $23 at Maxim Group on 2Q Report; 'Solid Revenues... Transformation Underway' Aug 2, 2017 03:35PM
Maxim Group Reiterates Buy Rating and $21 PT on Sucampo Pharmaceuticals (SCMP); 'We See Upside in the Stock' Apr 13, 2017 02:22PM
Sucampo Pharmaceuticals (SCMP) PT Raised to $21 at Maxim Group; Vtesse 'Could Be a Great Deal' Apr 3, 2017 03:20PM
Sucampo Pharmaceuticals (SCMP) PT Raised to $19 at Maxim Group Nov 15, 2016 07:33AM


Aug 5, 2015 03:48PM Sucampo (SCMP) PT Raised to $25 at Maxim Group
Jan 20, 2015 08:54AM Sucampo Pharmaceuticals (SCMP) PT Raised to $19 at Maxim Group
Dec 26, 2014 11:08AM Sucampo's (SCMP) Rescula Faces Generic Challenge, But It's Not a Factor - Maxim Group
Nov 6, 2014 03:15PM Sucampo Pharmaceutical (SCMP) PT Lifted to $14 at Maxim Group on Robust Amitza Growth
Oct 10, 2014 07:22AM UPDATE: Maxim Group Upgrades Sucampo Pharmaceuticals (SCMP) to Buy
Sep 3, 2013 08:01AM Maxim Group Downgrades Sucampo Pharmaceuticals (SCMP) to Hold
Mar 19, 2013 07:56AM Maxim Group Starts Sucampo Pharmaceuticals (SCMP) at Buy